Medtronic (MDT)
(Delayed Data from NYSE)
$81.04 USD
-0.62 (-0.76%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $81.04 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth D Momentum C VGM
Brokerage Reports
Medtronic PLC [MDT]
Reports for Purchase
Showing records 401 - 420 ( 504 total )
Company: Medtronic PLC
Industry: Medical - Products
Ongoing Challenges Hurt the Quarter; Maintain NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
Heart Rhythm Society Conference Takeaways
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
AFib Technology Update: Topera 3 Years Later
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
AFib Technology Update: Topera 3 Years Later
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
1Q Preview: Expecting a Seasonally Soft Quarter but Fundamentals Remain Intact
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
1Q Preview: Expecting a Seasonally Soft Quarter but Fundamentals Remain Intact
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
IN.PACT Meets Primary Endpoint, As Expected
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
ACC Weekend Recap: Raising MDT PT; STJ Remains Our Favorite Cardio Stock
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
Company: Medtronic PLC
Industry: Medical - Products
Company: Medtronic PLC
Industry: Medical - Products
F3Q14 Review: Generally In Line and Fairly Valued; Maintain NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
F3Q14 Review: Generally In Line and Fairly Valued; Maintain NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
IN.PACT DEEP Trial for Below-The-Knee Revascularization Fails to Meet Safety and Efficacy Endpoints
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
IN.PACT DEEP Trial for Below-The-Knee Revascularization Fails to Meet Safety and Efficacy Endpoints
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
Company: Medtronic PLC
Industry: Medical - Products
In-Line Quarter; Increase PT to $55, but Maintain NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
Preliminary 30-day Extreme Risk CoreValve Data Suggest Pluses and Minuses
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
Medical Devices - Bill to Repeal Medical Device Tax Gains Increasing Attention
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
Medtronic Receives FDA Approval of New Insulin Pump/Sensor
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
Model
Provider: WEDBUSH SECURITIES INC.